Treeline Biosciences Stock
HealthTechLooking to sell Treeline Biosciences stock or options?
Contact usFounded: 2021Funding to Date: $473M
Visit websiteTreeline Biosciences is a developer of transformative precision medicines designed to combat cancer and other severe diseases. The company's drug discovery platform incorporates mechanistic biology, medicinal chemistry, computational science, structural biology, and protein science. This allows medical professionals to effectively treat and potentially cure cancer.
Investors Include:
Casdin Capital, OrbiMed, Aisling Capital, Kohlberg Kravis Roberts, ARCH Venture Partners, Zeus Health, GV, Access Industries, Ajax Health, Rock Springs Capital, T. Rowe Price Group.